Skip Navigation

JNCI Journal of the National Cancer Institute 1999 91(14):1187-1189; doi:10.1093/jnci/91.14.1187
© 1999 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Jenks, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jenks, S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 91, No. 14, 1187-1189, July 21, 1999
© 1999 Oxford University Press

NEWS

Cancer Research Funding Now Has Many Financial Players

Susan Jenks

More than 3 decades after the initial ramp-up of federal funding for the nation's War on Cancer, the National Cancer Institute is still the largest single provider of funds for cancer research.

But other financial players — in particular, the pharmaceutical industry — have steeply increased their cancer research budgets, necessitating, according to a recent report, a reassessment of NCI's "planning and priority setting . . . to ensure that there is overall balance in the national cancer program."

The report, prepared for the National Cancer Policy Board, which addresses national . . . [Full Text of this Article]

Broadening Base

"Unique Status"


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?